1 – 10 of 261
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Prophylactic Treatment of Children with Hemophilia in Sweden
2024) In Seminars in Thrombosis and Hemostasis(
- Contribution to journal › Scientific review
-
Mark
Recombinant factor IX Fc for the treatment of hemophilia B
2024) In European Journal of Haematology(
- Contribution to journal › Scientific review
-
Mark
International Prophylaxis Study Group (IPSG) haemophilia joint MRI scale version 2.0
2024) In Haemophilia(
- Contribution to journal › Letter
-
Mark
Origin of pathogenic variant and mosaicism in families with a sporadic case of haemophilia B
2024) In Haemophilia(
- Contribution to journal › Article
-
Mark
Primary prophylaxis implementation and long-term joint outcomes in Swedish haemophilia A patients
2024) In Haemophilia(
- Contribution to journal › Article
- 2023
-
Mark
Factor VIII genotype and the risk of developing high-responding or low-responding inhibitors in severe hemophilia A : data from the PedNet Hemophilia Cohort of 1,202 children
(
- Contribution to journal › Article
-
Mark
The role of fibrinolysis in vascular diseases in UK biobank
(
- Contribution to journal › Letter
-
Mark
Dilemmas on emicizumab in children with haemophilia A : A survey of strategies from PedNet centres
(
- Contribution to journal › Article
-
Mark
Real-world prophylactic usage of recombinant factor IX Fc in Sweden : A report from the Swedish National Registry for bleeding disorders
(
- Contribution to journal › Letter
-
Mark
Haemophilia A and B - evaluation of the Swedish prophylactic regimen by magnetic resonance imaging
(
- Contribution to journal › Article